Dishman Carbogen Amcis Q2 Results
- BSE: 540701
- NSE: DCAL
- ISIN: INE385W01011
- Sector: Biotechnology & Drugs
BSE
177.35
2.45 (1.40%)
2.45 (1.40%)Volume14.21 K
Updated: Wed 13 May, 2026 | 15:29:00
NSE
176.101.27 (0.73%)
1.27 (0.73%)Volume1.44 L
Updated: Wed 13 May, 2026 | 15:53:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Dishman Carbogen Amcis Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 587.89 | 651.37 | -9.75% | 716.94 | -18.00% |
| Depreciation/ Amortization | 84.13 | 81.35 | 3.42% | 72.09 | 16.70% |
| Operating Income | 64.76 | 56.68 | 14.26% | 72.10 | -10.18% |
| Net Income | 65.27 | 23.41 | 178.81% | 33.09 | 97.25% |
| Other Operating Expenses Total | 136.51 | 117.38 | 16.30% | 130.29 | 4.77% |
| Net Income Before Taxes | 30.54 | 38.67 | -21.02% | 42.12 | -27.49% |
| Total Revenue | 652.65 | 708.05 | -7.82% | 789.04 | -17.29% |
| Selling/ General/ Admin Expenses Total | 332.94 | 351.90 | -5.39% | 319.73 | 4.13% |
| Diluted Normalized EPS | 4.16 | 1.59 | 161.29% | 2.26 | 84.21% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.